By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Daewoong Pharmaceutical Co., Ltd. 

163-3 Samsung-Dong, Kangnam-Gu

Seoul    135-090  Korea
Phone: 82-2-550-8800 Fax: 82-2-553-3530


SEARCH JOBS


Industry
Pharmaceutical






Company News
BioAlliance Pharma Signs A New Licensing Agreement With Daewoong Pharmaceutical Co., Ltd. For Sitavig®’S Commercialization In South Korea 4/2/2014 9:36:53 AM
Medivir AB (MVIRb.F), Daewoong Pharmaceutical Co., Ltd. Discontinue Hepatitis B Drug Development 9/6/2013 6:54:34 AM
Daewoong Pharmaceutical Co., Ltd. Purchases China's Liaoning Baifeng for $16 Million 8/5/2013 8:33:51 AM
Antares Pharma, Inc. (AIS) Enters Licensing Agreement with Daewoong Pharmaceutical Co., Ltd. for Oxybutynin Gel 3% in South Korea 1/17/2012 6:58:27 AM
Medivir AB (MVIRb.F) Signs Agreement with Daewoong Pharmaceutical Co., Ltd. to Distribute Xerclear(R) in China and Hong Kong 6/23/2011 11:12:38 AM
Medivir AB (MVIRb.F): Daewoong Pharmaceutical Co., Ltd. to Distribute Medivir's Xerclear(TM) in South Korea 8/24/2010 10:20:06 AM
Medivir AB (MVIRb.F) Outlicenses MIV-210 to Daewoong Pharmaceutical Co., Ltd. for Clinical Development 3/11/2010 9:48:56 AM
Daewoong Pharmaceutical Co., Ltd. Threatens Pfizer Inc. (PFE) (JOBS) Over Scrapped Deal 11/30/2009 7:27:06 AM
Eurand Enters Agreement With Daewoong Pharmaceutical Co., Ltd. (South Korea) for Once-Daily Extended Release Muscle Relaxant 8/1/2008 8:51:37 AM
DUSA Pharmaceuticals (DUSA) Announces Exclusive Agreement With Daewoong Pharmaceutical Co., Ltd. To Market DUSA's Levulan'R' Kerastick'R' For Photodynamic Therapy In Asian Territories 1/8/2007 10:31:40 AM
12
//-->